ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Sodium Chloride → 4-[(3-bromo-2-(2-(2-triphenylmethyl-2H-tetrazol-5-yl)phenyl)benzofuran-5-yl)methoxy]-2-ethyl-5,6,7,8-tetrahydroquinoline

HRID 1198655
印刷

反応式

HRID 1198655 の反応式
[CH2:1]([C:3]1[N:12]=[C:11]([CH2:13][CH3:14])[CH:10]=[C:9]2[C:4]=1[CH:5]=[CH:6][C:7](=O)N2)C.[Br:16][C:17]1[C:21]2[CH:22]=[C:23]([CH2:26]Br)[CH:24]=[CH:25][C:20]=2[O:19][C:18]=1[C:28]1[CH:33]=[CH:32][CH:31]=[CH:30][C:29]=1[C:34]1[N:35]=[N:36][N:37]([C:39]([C:52]2[CH:57]=[CH:56][CH:55]=[CH:54][CH:53]=2)([C:46]2[CH:51]=[CH:50][CH:49]=[CH:48][CH:47]=2)[C:40]2[CH:45]=[CH:44][CH:43]=[CH:42][CH:41]=2)[N:38]=1.CC(C)([O-:61])C.[K+].O1CCOCCOCCOCCOCCOCC1.[Cl-].[Na+]>O1CCCC1>[Br:16][C:17]1[C:21]2[CH:22]=[C:23]([CH2:26][O:61][C:9]3[C:4]4[CH2:5][CH2:6][CH2:7][CH2:1][C:3]=4[N:12]=[C:11]([CH2:13][CH3:14])[CH:10]=3)[CH:24]=[CH:25][C:20]=2[O:19][C:18]=1[C:28]1[CH:33]=[CH:32][CH:31]=[CH:30][C:29]=1[C:34]1[N:35]=[N:36][N:37]([C:39]([C:52]2[CH:57]=[CH:56][CH:55]=[CH:54][CH:53]=2)([C:46]2[CH:47]=[CH:48][CH:49]=[CH:50][CH:51]=2)[C:40]2[CH:45]=[CH:44][CH:43]=[CH:42][CH:41]=2)[N:38]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 5

HCID 5234Sodium ChlorideHCID 2855718-Crown-6HCID 189833195-[2-(3-bromo-5-(bromomethyl)benzofuran-2-yl)phenyl]-2-triphenylmethyl-2H-tetrazoleHCID 200942525,7-diethyl-[1,6]naphthyridin-2(1H)-oneHCID 23665647Potassium tert-butoxide

生成物 1

HCID 19102773
4-[(3-bromo-2-(2-(2-triphenylmethyl-2H-tetrazol-5-yl)phenyl)benzofuran-5-yl)methoxy]-2-ethyl-5,6,7,8-tetrahydroquinoline
収率 57.6%

試薬・触媒・溶媒 1

HCID 8028Tetrahydrofuran溶媒

実験手順

A mixture of 5,7-diethyl-1,6-naphthyridin-2(1H)-one (291 mg), 5-[2-(3-bromo-5-(bromomethyl)benzofuran-2-yl)phenyl]-2-triphenylmethyl-2H-tetrazole (1.30 g), potassium t-butoxide (168 mg) and 1,4,7,10,13,16-hexaoxacyclooctadecane (40 mg) in dry tetrahydrofuran (15 ml) was stirred under an atmosphere of argon for 18 hours. Saturated sodium chloride solution (25 ml) was added and the mixture was extracted with ether (2×25 ml). The extracts were dried (MgSO4) and concentrated by evaporation. The residue was purified by flash chromatography, eluting with ethyl acetate/hexane (3:1 v/v), to give 1-[(3-bromo-2-(2-(2-triphenylmethyl-2H-tetrazol-5-yl)phenyl)benzofuran-5-yl)methyl]-5,7-diethyl-1,6-naphthyridin-2(1H)-one (A) (640 mg) as a foam; NMR: 1.2(t, 3H), 1.35(t, 3H), 2.7(q, 2H), 3.1(q, 2H), 5.6(s, 2H), 6.8-7.25(m, 19 H), 7.35(s, 1H), 7.5-7.7(m, 3H), 8.0(d, 1H), 8.2(d, 1H).

後処理

  1. extractionthe mixture was extracted with ether (2×25 ml)
  2. dry with materialThe extracts were dried (MgSO4)
  3. concentrationconcentrated by evaporation
  4. customThe residue was purified by flash chromatography
  5. washeluting with ethyl acetate/hexane (3:1 v/v)

出典と根拠

ORDレコード
ord-c9b12aead6d64663b9fa99220ba3df81
出典データセット
uspto-grants-1994_01
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US05281613

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート